Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mid Hudson Medical Research is a private, multi-specialty clinical research organization and trial site network based in New Windsor, New York, serving the Hudson Valley region. The organization conducts industry-sponsored FDA-regulated studies across therapeutic products, vaccines, diagnostics, and medical devices in outpatient and primary-care settings. Its therapeutic focus spans neurology, cardiology, endocrinology/metabolism, pulmonology, gastroenterology, urology, orthopedics, infectious disease, dermatology, pain management, and women's health. The company appears to operate primarily as a clinical trial site and service provider rather than a drug developer with a proprietary therapeutic pipeline. Its leadership is centered around principal investigator Dr. Sashi Makam, with operations designed to recruit patients and execute Phase II-IV studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mid Hudson Medical Research.